References
- Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367(9516):1066. doi:10.1016/S0140-6736(06)68397-9.
- World Health Organization (WHO). The World Health Report 2005-Make every mother and child count. Geneva, Switzerland, 2005. http://www.who.int/whr/2005/en/
- Osungbade KO, Ige KO. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095. doi:10.1155/2011/481095.
- PopulationCouncil. 2008. http://www.popcouncil.org/projects/RH_NigeriaMgSO4.html
- Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J ObstetGynaecol Can. 2008;30(10):918–49.
- Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am SocNephrol. 2007;2(3):543–49. doi:10.2215/CJN.03761106
- Karaman E, Karaman Y, Alkis I, Han A, Yildrim G, Ark HC. Maternal serum CA125 level is elevated in severe preeclampsia. Pregnancy Hypertens. 2014;4(1):29–33. doi:10.1016/j.preghy.2013.08.003
- Cebesoy FB, Ozcan B, Ebru D, Hakan K, Yelda I. CA125 and CRP are elevated in preeclampsia. Hypertens Pregnancy. 2009;28(2):201–11. doi:10.1080/10641950802601187
- Moss EL, Hollingworth J, Reynolds TM. The role of CA125 in clinical practice. J ClinPathol. 2005;58(3):308–12.
- Ozat M, Kanat-Pektas M, Okan Y, Tayfun G, Nuri D, Mollamahmutoglu L. Serum concentrations of CA-125 in normal and preeclamptic pregnancies. Arch GynecolObstet. 2010;284(3):607–12.
- Sedigheh A, Fatemeh VR, Fatemeh T. CA125 in normal pregnancy and threatened abortion. Iran J Reprod Med. 2007;5(2):57–60.
- Schmidt T, Rein DT, Foth D, Eibach HW, Kurbacher CM, Mallmann P, et al. Prognostic value of repeated serum CA125 measurements in first trimester of pregnancy. Eur J ObstetGyneacolreprod Biol. 2001;97(2):168–73.
- Tyler C, Kapur A, Felder M, Belisle JA, Trautman C, Gubbels JAA, et al. The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia. Am J Reprod Immunol. 2012;68(1):28–37.
- National High Blood Pressure Education Program Working Group (2000) Report on high blood pressure in pregnancy. Washington (DC): National Institutes of Health. National Institutes of Health Publication No. 00-3029.
- Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467–74.
- Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician. 2004;70(12):2317–24.
- Schröcksnadel H, Daxenbichler G, Artner E, Steckel-Berger G, Dapunt O. Tumor markers in hypertensive disorders of pregnancy. GynecolObstet Invest. 1993;35:204–08. doi:10.1159/000292701.
- Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, Van Kamp GJ, Van Geijn HP, Van Vugt JM. Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy. Fetal DiagnTher. 2001;16(3):166–72. doi:10.1159/000053903
- De Groot CJ, O’Brien TJ, Taylor RN. Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am J ObstetGynecol. 1996;175(1):24–29. doi:10.1016/S0002-9378(96)70245-4